尊龙凯时®心脉医疗™
2022年12月31日为准【单位:千美元】
业务指标 | FYE 12/2013 (reatated*) |
FYE 12/2014 | FYE 12/2015 | FYE 12/2016 | FYE 12/2017 | FYE 12/2018 | FYE 12/2019 | FYE 12/2020 | FYE 12/2021 | FYE 12/2022 |
---|---|---|---|---|---|---|---|---|---|---|
营业额 | 151,655 | 355,284 | 375,844 | 389,921 | 444,190 | 669,490 | 793,493 | 648,732 | 778,639 |
840,831 |
毛利 | 122,878 | 243,285 | 252,509 | 271,678 | 318,397 | 470,016 | 564,425 | 436,032 | 491,773 |
501,771 |
研究及开发成本 | (29,195) | 54,564 | (60,354) | (51,897) | (58,150) | (104,814) | (151,486) | (192,629) | (297,778) |
(419,828) |
分销成本 | (25,630) | 133,629 | (127,739) | (128,464) | (137,766) | (217,792) | (275,266) | (254,105) | (297,532) |
(328,232) |
行政开支 | (19,259) | 70,773 | (65,031) | (64,245) | (66,804) | (95,742) | (119,345) | (170,105) | (250,010) |
(247,532) |
年内利润 | (23,997) | 59,571 | (11,379) | 15,069 | 16,951 | 18,381 | 29,009 | (223,348) | (351,295) |
(588,115) |
每股盈利-基本(美分) | (1.71) | 4.22 | (0.85) | 0.99 | 1.31 | 1.63 | 2.92 | (10.97) | (15.29) |
(24.08) |
资产净额 | 390,433 | 343,743 | 317,828 | 346,479 | 439,452 | 528,946 | 653,965 | 1,387,946 | 2,217,492 |
1,792,668 |
股东权益比率(%) | 75.25 | 36.42 | 43.32 | 44.73 | 48.63 | 41.50 | 40.93 | 56.21 | 50.62 |
44.88 |
总资产 | 518,846 | 939,734 | 733,643 | 774,550 | 903,623 | 1,274,447 | 1,597,951 | 2,469,133 | 4,380,529 |
3,994,085 |
经营产生的现金 | 57,753 | 17,806 | 30,720 | 82,534 | 97,186 | 84,130 | 26,451 | (23,200) | (257,530) |
(343,303) |
年末已发行流通股票(千股) | 1,408,995 | 1,422,160 | 1,426,569 | 1,439,481 | 1,457,063 | 1,602,326 | 1,622,778 | 1,809,540 | 1,820,751 | 1,827,618 |
©Copyright 1998-2024, MicroPort Scientific Corporation. All rights reserved. 技术支持:唯引互动 | 网站备案/许可证号:沪ICP备43173442号 沪公网安备 31011502014876号
互联网药品信息服务资格证书编号:(沪)- 非经营性 - 2016 - 0131
“尊龙凯时”、“MicroPort”及“ ”为我司注册商标,未经许可不得擅自使用。